Neogenomics Inc logo

NEO - Neogenomics Inc News Story

$30.09 -0.4  -1.3%

Last Trade - 2:35pm

Large Cap
Market Cap £2.84bn
Enterprise Value £2.83bn
Revenue £366.3m
Position in Universe 1693rd / 7306

BUZZ-Guardant down on report of talks to buy diagnostic firm NeoGenomics

Fri 1st October, 2021 3:53pm
** Shares of cancer diagnostics firm NeoGenomics Inc  NEO.O 
up 8.1% at $52.3, while cancer test maker Guardant  GH.O  down
13.5% at $108
    ** Guardant Health is in talks to buy NEO, Bloomberg News
reported, citing people familiar with the matter (
    ** Discussions are ongoing and there is no certainty it will
lead to an offer from Guardant - Bloomberg
    ** NEO has a market cap of $5.9 bln, while GH's market cap
is $12.66 bln, according to Refinitiv data
    ** NEO declined to comment on market speculation 
    ** GH down 13.4% so far this year, while NEO down 3.2% YTD

 (Reporting by Dania Nadeem in Bengaluru)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.